Related Experiment Videos

Plain film and CT observations in prostaglandin-induced bone changes

M A Matzinger1, V A Briggs, H J Dunlap

  • 1Department of Radiology, Children's Hospital of Eastern Ontario, Ottawa, Canada.

Pediatric Radiology
|January 1, 1992
PubMed

Insights

Prostaglandin E1 infusions for congenital heart defects can cause bone disease in infants. This study highlights radiographic signs like periosteal proliferation and bone-within-bone appearance.

Area of Science:

  • Pediatric Cardiology
  • Pediatric Radiology
  • Medical Imaging

Background:

  • Prostaglandin E1 (PGE1) infusions are critical for infants with ductal-dependent congenital heart disease.
  • PGE1 maintains ductal patency, enabling survival until surgical intervention.
  • PGE1 administration is associated with various complications, including bone abnormalities.

Purpose of the Study:

  • To describe the plain radiographic features of prostaglandin-induced bone disease in infants.
  • To correlate these radiographic findings with CT imaging.
  • To increase awareness of this iatrogenic complication.

Main Methods:

  • Review of plain radiographs in infants receiving PGE1 infusions.
  • Identification of characteristic bone abnormalities.
  • Correlation with CT scans for detailed assessment.

Main Results:

  • Dramatic plain radiographic findings of prostaglandin-induced bone disease were observed.
  • Key features included periosteal proliferation and a unique bone-within-bone appearance.
  • CT correlation confirmed and elucidated these skeletal changes.

Conclusions:

  • Prostaglandin E1 can induce distinctive bone abnormalities in infants.
  • Radiographic signs such as periosteal proliferation and bone-within-bone are indicative of this condition.
  • Radiologists and clinicians should be aware of these iatrogenic bone changes.

Related Concept Videos